Synergistic Effect of EZH2 Knockdown and Irradiation Against Pancreatic Cancer Cells

被引：0
作者：
Gupta, Raavi
Agrawal, Raag
Martello-Rooney, Laura
Haseeb, M.
机构：
[1] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA
[2] SUNY Downstate, Brooklyn, NY USA
来源：
MODERN PATHOLOGY | 2015年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1831
引用
收藏
页码：457A / 457A
页数：1
相关论文
共 50 条
  • [31] EZH2: An Accomplice of Gastric Cancer
    Yu, Wuhan
    Liu, Ning
    Song, Xiaogang
    Chen, Lang
    Wang, Mancai
    Xiao, Guohui
    Li, Tengfei
    Wang, Zheyuan
    Zhang, Youcheng
    CANCERS, 2023, 15 (02)
  • [32] The noncanonical role of EZH2 in cancer
    Huang, Jinhua
    Gou, Hongwei
    Yao, Jia
    Yi, Kaining
    Jin, Zhigang
    Matsuoka, Masao
    Zhao, Tiejun
    CANCER SCIENCE, 2021, 112 (04) : 1376 - 1382
  • [33] Diosgenin exhibits tumor suppressive function via down-regulation of EZH2 in pancreatic cancer cells
    Guo, Wenhao
    Chen, Yujia
    Gao, Jinsheng
    Zhong, Kunhong
    Wei, Heng
    Li, Ke
    Tang, Mei
    Zhao, Xinyu
    Liu, Xinyu
    Nie, Chunlai
    Yuan, Zhu
    CELL CYCLE, 2019, 18 (15) : 1745 - 1758
  • [34] Study on the Effect of EZH2 Inhibitor Combined with TIGIT Monoclonal Antibody against Multiple Myeloma Cells
    Liu, Zhaoyun
    Jia, Yue
    Yang, Chun
    Liu, Hui
    Shen, Hongli
    Wang, Hao
    Fu, Rong
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (10)
  • [35] The role of EZH1 and EZH2 in development and cancer
    Lee, Soo Hyun
    Li, Yingying
    Kim, Hanbyeol
    Eum, Seounghyun
    Park, Kyumin
    Lee, Chul-Hwan
    BMB REPORTS, 2022, 55 (12) : 595 - 601
  • [36] EZH2 couples pancreatic regeneration to neoplastic progression
    Mallen-St Clair, Jon
    Soydaner-Azeloglu, Rengin
    Lee, Kyoung Eun
    Taylor, Laura
    Livanos, Alexandra
    Pylayeva-Gupta, Yuliya
    Miller, George
    Margueron, Raphael
    Reinberg, Danny
    Bar-Sagi, Dafna
    GENES & DEVELOPMENT, 2012, 26 (05) : 439 - 444
  • [37] Study of Novel Inhibitor of EZH2/PRC2 in Cancer Cells
    Murashima, Akihiro
    Shinjo, Keiko
    Katsushima, Keisuke
    Onuki, Tetsuo
    Ito, Akihiro
    Yoshida, Minoru
    Kondo, Yutaka
    CANCER SCIENCE, 2018, 109 : 1175 - 1175
  • [38] Identification of potential inhibitors for EZH2/PRC2 in cancer cells
    Murashima, Akihiro
    Shinjo, Keiko
    Dohi, Natsuki
    Katsushima, Keisuke
    Ito, Akihiro
    Onuki, Tetsuo
    Yoshida, Minoru
    Kondo, Yutaka
    CANCER SCIENCE, 2018, 109 : 621 - 621
  • [39] Potential Effect of Ezh2 in mediating RAD51, INK/ARF, and DAB2IP Gene Expression in Pancreatic Cancer Cells
    Habib, Asad
    Pan, Weihao
    Alzofon, Nathaniel
    Wang, Shengzhou
    Urayama, Shiro
    GASTROENTEROLOGY, 2016, 150 (04) : S329 - S329
  • [40] TP53-Status-Dependent Oncogenic EZH2 Activity in Pancreatic Cancer
    Versemann, Lennart
    Patil, Shilpa
    Steuber, Benjamin
    Zhang, Zhe
    Kopp, Waltraut
    Krawczyk, Hannah Elisa
    Kaulfuss, Silke
    Wollnik, Bernd
    Stroebel, Philipp
    Neesse, Albrecht
    Singh, Shiv K.
    Ellenrieder, Volker
    Hessmann, Elisabeth
    CANCERS, 2022, 14 (14)
12345